Alexandra Sklan interviews Mike Butler, Xceleron about Xceleron’s recent move to the USA and the implications of this relocation on the development of bioanalytical studies.
Interview with Tim Sangster (Charles River Laboratories) and Mike Oliver (Thermo Fisher Scientific) on the challenges faced by the modern bioanalytical laboratory
Thomas Payne interviews Tim Sangster, Charles River Laboratories and Mike Oliver, Thermo Fisher Scientific about the challenges faced by the modern bioanalytical laboratory.
Alexandra Sklan interviews Tom Astle, Tomtec about the variation in the results generated in two recent hematocrit DBS analytical studies.
Interview with David A Cowan (King’s College London) and Campbell P Baker (GlaxoSmithKline) on partnering with the industry: the Olympic laboratory model
Ryan De Vooght-Johnson interviews David A Cowan, Director of the King’s College London Drug Control Centre, and Campbell P Barker, GlaxoSmithKline about the partnership between industry and academia for the setup and running of the doping-control laboratory for the London 2012 Olympic Games.
Bioanalysis Zone interviews Christophe Stove, Ghent University, about the challenges of DBS, and its future in bioanalysis.
Thomas Payne interviews Dr Alan Breau, MPI Research, about his work in the bioanalytical field and his opinions on the pharmaceutical industry.
Thomas Payne interviews Chris Molloy, IDBS, about software solutions for pharma R&D.
Thomas Payne interviews Dr Chris Beaver, inVentiv Health Clinical, about GLP compliance.
Thomas Payne interviews Dr Michael Zhou, BASi about new technologies and the need for harmonised guidelines.
Thomas Payne interviews Dr Shane Needham, Alturas Analytics about his work with LC-MS.